Page 1 of Clinical Trials for Karo Bio AB [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia
Last Updated: October 20, 2008
Condition(s): Primary Hypercholesterolemia
2
Completed
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin
Last Updated: November 27, 2008
Condition(s): Dyslipidemia
3
Completed
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe
Last Updated: November 27, 2008
Condition(s): Hypercholesterolemia
4
Recruiting
Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care
Last Updated: October 19, 2011
Condition(s): Heterozygous Familial Hypercholesterolaemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Karo+Bio+AB

Page 1 of Clinical Trials for Karo Bio AB [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About